Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03941756 · ClinicalTrials.gov registry record · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
A NA study of Melanoma and Anatomic Stage III Breast Cancer AJCC v8, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 1
- Study location
NCT03941756 is a NA study of Melanoma and Anatomic Stage III Breast Cancer AJCC v8 that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 252 participants, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03941756, a NA study of Melanoma and Anatomic Stage III Breast Cancer AJCC v8, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot trial studies whether a procedure called lymphovenous bypass would prevent lymphedema (arm swelling) in patients with inflammatory breast cancer or non-inflammatory breast cancer that has spread to nearby tissues or lymph nodes or melanoma. The lymphovenous bypass procedure creates a path for lymphatic fluid to flow away from the arms. It is usually done after a diagnosis of lymphedema. In this study, giving lymphovenous bypass before underarm lymph node surgery may help prevent lymphedema from forming.
Conditions Studied
Interventions
- DRUG Indocyanine Green
- PROCEDURE Lymphangiography
- PROCEDURE Lymphovenous Bypass
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2018-08-14 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03941756
The ClinicalTrials.gov registry entry for NCT03941756 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (64% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Melanoma appearing as the primary indexed condition, and to 3 interventions - of which Indocyanine Green is the first listed.
NCT03941756 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03941756 about?
NCT03941756 is a clinical study titled "Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma". This pilot trial studies whether a procedure called lymphovenous bypass would prevent lymphedema (arm swelling) in patients with inflammatory breast cancer or non-inflammatory breast cancer that has spread to nearby tissues or lymph nodes or melanoma. The lymphovenous bypass procedure creates a path...
What is the current status of trial NCT03941756?
This trial is currently recruiting. It is a NA study. The enrollment target is 252 participants. The study started on 2018-08-14. Estimated completion is 2025-12-31.
What conditions does trial NCT03941756 study?
This clinical trial studies the following conditions: Melanoma, Anatomic Stage III Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma, Breast Inflammatory Carcinoma.
What interventions are being tested in trial NCT03941756?
The interventions under investigation include: Indocyanine Green (DRUG), Lymphangiography (PROCEDURE), Lymphovenous Bypass (PROCEDURE).
Who is sponsoring clinical trial NCT03941756?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03941756 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
-
In Vivo Liquid Biopsy of Melanoma (Cytophone)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.